Introducing health technology assessment in Tanzania.


Journal

International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 14 8 2019
medline: 10 3 2021
entrez: 13 8 2019
Statut: ppublish

Résumé

Health technology assessment (HTA) is a cost-effective resource allocation tool in healthcare decision-making processes; however, its use is limited in low-income settings where countries fall short on both absorptive and technical capacity. This paper describes the journey of the introduction of HTA into decision-making processes through a case study revising the National Essential Medicines List (NEMLIT) in Tanzania. It draws lessons on establishing and strengthening transparent priority-setting processes, particularly in sub-Saharan Africa. The concept of HTA was introduced in Tanzania through revision of the NEMLIT by identifying a process for using HTA criteria and evidence-informed decision making. Training was given on using economic evidence for decision making, which was then put into practice for medicine selection for the NEMLIT. During the revision process, capacity-building workshops were held with reinforcing messages on HTA. Between the period 2014 and 2018, HTA was introduced in Tanzania with a formal HTA committee being established and inaugurated followed by the successful completion and adoption of HTA into the NEMLIT revision process by the end of 2017. Consequently, the country is in the process of institutionalizing HTA for decision making and priority setting. While the introduction of HTA process is country-specific, key lessons emerge that can provide an example to stakeholders in other low- and middle-income countries (LMICs) wishing to introduce priority-setting processes into health decision making.

Identifiants

pubmed: 31402790
doi: 10.1017/S0266462319000588
pii: S0266462319000588
doi:

Substances chimiques

Drugs, Essential 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-86

Subventions

Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Auteurs

Gavin Surgey (G)

SA MRC/ Wits Centre for Health Economics and Decision Science-PRICELESS SA, University of Witwatersrand Faculty of Health Sciences School of Public Health, Johannesburg, South Africa.
Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.

Kalipso Chalkidou (K)

Global Health Policy, Centre for Global Development, Washington, DC, USA.
School of Public Health, Imperial College London, London, UK.

William Reuben (W)

Pharmaceutical Services Unit, Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, United Republic of Tanzania.

Fatima Suleman (F)

College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Jacqui Miot (J)

Health Economics and Epidemiology Research Office, University of Witwatersrand, Johannesburg, South Africa.

Karen Hofman (K)

SA MRC/ Wits Centre for Health Economics and Decision Science-PRICELESS SA, University of Witwatersrand Faculty of Health Sciences School of Public Health, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH